|
|
|
Insider
Information: |
Stampacchia Otello |
Relationship: |
Director |
City: |
George Town, Grand Cayman |
State: |
E9 |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
6 |
|
Direct
Shares |
17,297,599 |
|
Indirect Shares
|
21,254,784 |
|
|
Direct
Value |
$95,246,388 |
|
|
Indirect Value
|
$122,302,720 |
|
|
Total
Shares |
38,552,383 |
|
|
Total
Value |
$217,549,108 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
3
|
Stock
price went up :
|
0
|
3
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
3.0
|
Percentage
Gain/Loss : |
0.0%
|
78.1%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Gossamer Bio Inc |
GOSS |
Former director., 10% ... |
2019-09-18 |
6,737,023 |
2019-02-12 |
6,953,416 |
Premium* |
|
Morphic Holding, Inc. |
MORF |
Director |
2021-04-30 |
2,068,913 |
2019-07-01 |
2,969,582 |
Premium* |
|
Replimune Group Inc |
REPL |
10% Owner |
2022-03-16 |
4,673,380 |
2022-03-14 |
4,763,380 |
Premium* |
|
Kronos Bio, Inc. |
KRON |
Director |
2020-10-14 |
3,818,283 |
2020-10-14 |
3,818,283 |
Premium* |
|
Omega Alpha Spac |
OMEG |
Chief Executive Office... |
|
0 |
2021-01-11 |
501,000 |
Premium* |
|
Ikena Oncology, Inc. |
IKNA |
Director |
2021-03-30 |
0 |
2021-03-30 |
2,249,123 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
119 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 5
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
GOSS |
Gossamer Bio Inc |
Director |
|
2019-02-12 |
4 |
A |
$0.00 |
$0 |
I/I |
6,953,416 |
6,953,416 |
0 |
- |
|
MORF |
Morphic Holding, Inc. |
Director |
|
2019-07-01 |
4 |
B |
$15.00 |
$1,999,995 |
I/I |
133,333 |
2,969,582 |
2.25 |
- |
|
MORF |
Morphic Holding, Inc. |
Director |
|
2019-07-01 |
4 |
A |
$0.00 |
$0 |
I/I |
2,836,249 |
2,836,249 |
0 |
- |
|
MORF |
Morphic Holding, Inc. |
Director |
|
2019-07-01 |
4 |
B |
$15.00 |
$1,999,995 |
D/D |
133,333 |
2,969,582 |
3.92 |
- |
|
MORF |
Morphic Holding, Inc. |
Director |
|
2019-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
2,836,249 |
2,836,249 |
0 |
- |
|
GOSS |
Gossamer Bio Inc |
Director |
|
2019-09-05 |
4 |
S |
$21.60 |
$274,434 |
D/D |
(12,704) |
6,940,712 |
0 |
- |
|
GOSS |
Gossamer Bio Inc |
Director |
|
2019-09-06 |
4 |
S |
$21.51 |
$187,103 |
D/D |
(8,700) |
6,932,012 |
0 |
- |
|
GOSS |
Gossamer Bio Inc |
Director |
|
2019-09-10 |
4 |
S |
$21.00 |
$679,865 |
D/D |
(32,373) |
6,899,639 |
0 |
- |
|
GOSS |
Gossamer Bio Inc |
Director |
|
2019-09-11 |
4 |
S |
$21.31 |
$1,713,629 |
D/D |
(80,403) |
6,819,236 |
0 |
- |
|
GOSS |
Gossamer Bio Inc |
Former director. |
|
2019-09-16 |
4 |
S |
$21.52 |
$284,331 |
D/D |
(13,213) |
6,806,023 |
0 |
- |
|
GOSS |
Gossamer Bio Inc |
Former director. |
|
2019-09-17 |
4 |
S |
$21.62 |
$505,791 |
D/D |
(23,400) |
6,782,623 |
0 |
- |
|
GOSS |
Gossamer Bio Inc |
Former director. |
|
2019-09-18 |
4 |
S |
$21.88 |
$997,637 |
D/D |
(45,600) |
6,737,023 |
0 |
- |
|
REPL |
Replimune Group Inc |
Director |
|
2019-11-18 |
4 |
B |
$13.61 |
$2,994,200 |
D/D |
220,000 |
5,328,939 |
3.92 |
- |
|
KRON |
Kronos Bio, Inc. |
Director |
|
2020-10-14 |
4 |
A |
$0.00 |
$5,915,729 |
D/D |
3,348,832 |
3,368,283 |
0 |
- |
|
KRON |
Kronos Bio, Inc. |
Director |
|
2020-10-14 |
4 |
B |
$19.00 |
$8,550,000 |
D/D |
450,000 |
3,818,283 |
2.39 |
- |
|
KRON |
Kronos Bio, Inc. |
Director |
|
2020-10-14 |
4 |
A |
$0.00 |
$5,915,729 |
I/I |
3,348,832 |
3,368,283 |
0 |
- |
|
KRON |
Kronos Bio, Inc. |
Director |
|
2020-10-14 |
4 |
B |
$19.00 |
$8,550,000 |
I/I |
450,000 |
3,818,283 |
2.25 |
- |
|
MORF |
Morphic Holding, Inc. |
Director |
|
2020-12-23 |
4 |
AS |
$33.34 |
$305,162 |
D/D |
(9,142) |
2,968,690 |
0 |
% |
|
MORF |
Morphic Holding, Inc. |
Director |
|
2020-12-24 |
4 |
AS |
$32.48 |
$94,220 |
D/D |
(2,883) |
2,965,807 |
0 |
% |
|
MORF |
Morphic Holding, Inc. |
Director |
|
2020-12-28 |
4 |
AS |
$32.34 |
$306,266 |
D/D |
(9,466) |
2,956,341 |
0 |
% |
|
MORF |
Morphic Holding, Inc. |
Director |
|
2020-12-29 |
4 |
AS |
$31.75 |
$331,149 |
D/D |
(10,428) |
2,945,913 |
0 |
% |
|
MORF |
Morphic Holding, Inc. |
Director |
|
2021-01-04 |
4 |
AS |
$32.57 |
$396,305 |
D/D |
(12,118) |
2,917,903 |
0 |
% |
|
MORF |
Morphic Holding, Inc. |
Director |
|
2021-01-05 |
4 |
AS |
$30.89 |
$414,088 |
D/D |
(13,324) |
2,904,579 |
0 |
% |
|
MORF |
Morphic Holding, Inc. |
Director |
|
2021-01-06 |
4 |
AS |
$30.09 |
$361,923 |
D/D |
(12,024) |
2,892,555 |
0 |
% |
|
MORF |
Morphic Holding, Inc. |
Director |
|
2021-01-07 |
4 |
AS |
$29.98 |
$483,907 |
D/D |
(16,141) |
2,876,414 |
0 |
% |
|
119 Records found
|
|
Page 1 of 5 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|